Year: 2026
Type: article
Study design: Observational Study
Abstract: Neurologists often re-test MOG-IgG, but the frequency and factors associated with serostatus change are unknown. We examined this issue in a clinical cohort of patients serially tested for MOG-IgG at Cleveland Clinic between 2017 and 2025. Kaplan-Meier curves estimated seroconversion/seroreversion-free probability. Of 272 with serial testing, 16 seroreverted (to negative), 4 seroconverted (to positive). At 1 year, seroreversion-free probability was 85% (95% CI: 76%, 96%) and seroconversion-free probability was 98% (95% CI: 95%, 100%). Seroreversion occurred in 16 of 59 (27%), of whom 11 had titers < 1:100; none had further relapses. Seroconversion was uncommon (< 2%) and occurred in patients with steroid treatment at initial testing.
DOI: 10.1002/acn3.70551
Institution: Cleveland Clinic
Language: English
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $4,100
OpenAlex ID: W7232107256
